Dementia News and Research

Latest Dementia News and Research

MU researcher receives $2.2 million grant to develop system to display clear blood pressure information

Physicians receive lots of information about patients in a short amount of time, and sometimes that information is scattered, disorganized or difficult to comprehend. Now, a researcher at the University of Missouri School of Medicine has received funding to develop a simpler and clearer system to display blood pressure information.

21 Jul 2015

Stanford researchers identify iron-containing microglia in the brains of people with Alzheimer's disease

Examining post-mortem tissue from the brains of people with Alzheimer's disease, Stanford University School of Medicine investigators identified what appear to be iron-containing microglia -- specialized scavenger cells that sometimes become inflammatory -- in a particular part of the hippocampus, a key brain structure whose integrity is critical to memory formation.

21 Jul 2015

Alzheimer's Association recognizes four scientists with Lifetime Achievement Awards at AAIC 2015

The Alzheimer's Association recognizes four leading scientists for their contributions to advancing Alzheimer's disease and dementia research. The awards were presented during the opening session at the Alzheimer's Association International Conference 2015 in Washington, D.C.

21 Jul 2015

MetLife Foundation Awards for Medical Research presented at AAIC 2015

At the Alzheimer's Association International Conference 2015 in Washington D.C., MetLife Foundation presented its annual MetLife Foundation Awards for Medical Research. These awards were presented to Randall Bateman, M.D., and Christian Haass, Ph.D., for their contributions in advancing Alzheimer's disease research.

21 Jul 2015

Allergan announces U.S. availability of SAPHRIS 2.5 mg tablets for children with bipolar I disorder

Allergan plc today announced that SAPHRIS (asenapine) 2.5 mg sublingual (placed under the tongue) black-cherry flavored tablets are available in pharmacies throughout the U.S. In March 2015, the U.S. Food and Drug Administration approved SAPHRIS for the acute treatment of manic or mixed episodes associated with bipolar I disorder in pediatric patients (ages 10 – 17).

17 Jul 2015

Older people who screen positive for dementia refuse subsequent evaluation, study finds

Two thirds of individuals 65 and older who screened positive for cognitive impairment refused subsequent evaluation according to the first study of its kind to examine older adults' willingness to undergo diagnostic assessment. The Indiana University Center for Aging Research, Regenstrief Institute and Eskenazi Health study of approximately 500 older adults found that individuals living alone were the least likely to agree to diagnostic assessment following a positive screening test for dementia.

17 Jul 2015

Type 2 diabetes patients with specific genetic markers at higher risk of developing Alzheimer's disease

Certain patients with type 2 diabetes (T2D) may have specific genetic risk factors that put them at higher risk for developing Alzheimer's disease (AD), according to a study conducted at the Icahn School of Medicine at Mount Sinai and published recently in Molecular Aspects of Medicine.

17 Jul 2015

Having high blood pressure in midlife can affect cognition many years later

Having high blood pressure in your 50's may impact your ability to keep track or plan ahead in your 80's. This study reports a connection between high blood pressure at a younger age can affect cognition many years later. It currently appears in the Journal of Alzheimer's Disease.

17 Jul 2015

Einstein-Montefiore researchers to present multiple findings at Alzheimer's Association International Conference

Investigators at Montefiore Health System and Albert Einstein College of Medicine of Yeshiva University will present multiple findings at the Alzheimer's Association International Conference, taking place July 18-23 in Washington, D.C. Research topics include risk factors for developing amnestic mild cognitive impairment (aMCI)—a condition characterized by memory problems, and is most often a precursor of Alzheimer's dementia.

16 Jul 2015

New research offers potential for early intervention to prevent neurodegenerative diseases

New research led by investigators at Beth Israel Deaconess Medical Center provides the first direct evidence linking traumatic brain injury to Alzheimer's disease and chronic traumatic encephalopathy (CTE) -- and offers the potential for early intervention to prevent the development of these debilitating neurodegenerative diseases.

16 Jul 2015

Potential diagnostic approach may detect individuals at increased risk for Alzheimer's disease

Individuals with amnestic mild cognitive impairment (aMCI) are at twice the risk of others in their age group of progressing to Alzheimer's disease. Although no conclusive test exists to predict who will develop Alzheimer's, new research from the Center for BrainHealth at The University of Texas at Dallas is attempting to identify a potential biomarker that could offer a more complete picture of who is most at risk.

16 Jul 2015

Research breakthrough opens door to a world of regenerative medicine for treating mitochondrial disease

A study led by Shoukhrat Mitalipov, Ph.D., and Hong Ma, M.D., Ph.D., at the Center for Embryonic Cell and Gene Therapy at Oregon Health & Science University and the Oregon National Primate Research Center has revealed the first critical step in developing novel gene and stem cell therapy treatments for patients with mitochondrial disease.

16 Jul 2015

Researchers identify gene that underlies thinking skills

An international team of researchers, including investigators from the University of Mississippi Medical Center, has identified a gene that underlies healthy information processing -- a first step on a complicated road to understand cognitive aging and age-related diseases, such as Alzheimer's disease.

16 Jul 2015

U of T researchers discover new details about key gene involved in ALS

A University of Toronto research team has discovered new details about a key gene involved in ALS, perhaps humanity's most puzzling, intractable disease.

16 Jul 2015

Alzheimer's disease may be 'at work' years ahead of actual symptoms, say IU researchers

The best-known genetic variant linked to Alzheimer's disease may be "at work" promoting deposits of plaque in the brain long before any symptoms of the disease can be measured on tests, according to a national research study led by Indiana University School of Medicine investigators.

14 Jul 2015

Mylan announces launch of generic Namenda Tablets in U.S.

Mylan N.V. today announced the U.S. launch of Memantine Hydrochloride Tablets USP, 5 mg and 10 mg, which is the generic version of Forest's Namenda Tablets.

14 Jul 2015

New study reveals strategy to improve interactions between physicians and patients

Physicians in their medical residency training programs often focus on scientific reasoning and research evidence in their efforts to provide medical care. While appropriate, this focus may overshadow subtle and indirect communication that reveals important information about the patient's experience with their illness that will help the physician provide better care.

14 Jul 2015

UBC research finds that gender plays vital role in healthy diets for seniors

Strategies to support healthier diets among seniors need to take into account differences between elderly men and women, according to UBC research.

10 Jul 2015

Design4Health conference to demonstrate innovative approaches to global healthcare issues

A 3D-printable prosthetic foot, a low cost tool to help prevent the spread of Ebola and tartan designed by people with Alzheimer’s disease are just some of the projects on show at a conference looking at innovative new approaches to global healthcare issues.

From Sheffield Hallam University 9 Jul 2015

Changes in key biomarkers of Alzheimer’s disease during midlife may help predict future dementia risk

Studying brain scans and cerebrospinal fluid of healthy adults, scientists have shown that changes in key biomarkers of Alzheimer's disease during midlife may help identify those who will develop dementia years later, according to new research.

7 Jul 2015

Dementia News and Research

Latest Dementia News and Research

MU researcher receives $2.2 million grant to develop system to display clear blood pressure information

Stanford researchers identify iron-containing microglia in the brains of people with Alzheimer's disease

Alzheimer's Association recognizes four scientists with Lifetime Achievement Awards at AAIC 2015

MetLife Foundation Awards for Medical Research presented at AAIC 2015

Allergan announces U.S. availability of SAPHRIS 2.5 mg tablets for children with bipolar I disorder

Older people who screen positive for dementia refuse subsequent evaluation, study finds

Type 2 diabetes patients with specific genetic markers at higher risk of developing Alzheimer's disease

Having high blood pressure in midlife can affect cognition many years later

Einstein-Montefiore researchers to present multiple findings at Alzheimer's Association International Conference

New research offers potential for early intervention to prevent neurodegenerative diseases

Potential diagnostic approach may detect individuals at increased risk for Alzheimer's disease

Research breakthrough opens door to a world of regenerative medicine for treating mitochondrial disease

Researchers identify gene that underlies thinking skills

U of T researchers discover new details about key gene involved in ALS

Alzheimer's disease may be 'at work' years ahead of actual symptoms, say IU researchers

Mylan announces launch of generic Namenda Tablets in U.S.

New study reveals strategy to improve interactions between physicians and patients

UBC research finds that gender plays vital role in healthy diets for seniors

Design4Health conference to demonstrate innovative approaches to global healthcare issues

Changes in key biomarkers of Alzheimer’s disease during midlife may help predict future dementia risk

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Dementia News and Research

Latest Dementia News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in